Robopac will participate to the Pfizer Covid-19 vaccine rollout
publié le vendredi 18 décembre 2020
Approved by the FDA, the Covid-19 vaccine produced by pharmaceutical giant Pfizer will be rolled out throughout the US to fight the pandemic. Pfizer and the US government have agreed on the shipment of 3 million frozen doses to reach all areas of the country.
Market expert in the end-of-line packaging sector and technology partner to Pfizer, Robopac will be guaranteeing the vaccine’s packaging and transport safety following its contribution to the development of ad hoc solutions for the packaging of pharmaceutical products made by the American giant. Ecoplat Plus is the solution adopted by Pfizer for packaging the vaccine doses due to be distributed in the USA.
A wrapping turntable featuring state-of-the-art technology, it uses stretch film that guarantees advanced performance including maximum protection of the goods due to its reliability, strength, and ease of use. Ecoplat Plus technology also keeps film consumption down while ensuring product safety, which means a lower impact of the raw material used. The solution illustrates the commitment of Robopac to find high-performance and sustainable packaging solutions.
Its particular focus on the end-of-line equipment is backed by sensitivity to circular economy issues, resulting in a combination of technology, innovation, and sustainability. Demonstrating this, four TechLabs set up around the world offer a unique way of conducting research, concentrating above all on reducing the impact of plastic, and have delivered results including 60% less consumption and full recyclability of materials.
All rights reserved except agreement written by Emballage Digest or mention of the magazine